Literature DB >> 8333846

Differential effect of chronic nicotine administration on brain cytochrome P4501A1/2 and P4502E1.

H K Anandatheerthavarada1, J F Williams, L Wecker.   

Abstract

The effects of chronic nicotine administration on the enzymatic activities and immunoreactivities of P4501A1/2 and P4502E1 were determined in microsomal fractions from brain regions and liver. Chronic nicotine increased 7-ethoxyresorufin O-deethylase activity and P4501A1/2 immunoreactivity in hippocampus and brain stem, decreased values in cerebral cortex, thalamus, and striatum, and did not affect parameters in other brain regions. In contrast, N-nitrosodimethylamine N-demethylase activity from nicotine-injected rats increased in all brain regions examined, and this increase was associated with increased P4502E1 immunoreactivity. Chronic nicotine did not alter either enzyme activities or immunoreactivities of these isoforms in hepatic microsomes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8333846     DOI: 10.1006/bbrc.1993.1821

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

Review 1.  Drug-metabolizing cytochrome P450s in the brain.

Authors:  Sharon L Miksys; Rachel F Tyndale
Journal:  J Psychiatry Neurosci       Date:  2002-11       Impact factor: 6.186

2.  Effect of nicotine on cytochrome P450 1A2 activity.

Authors:  Janne Hukkanen; Peyton Jacob; Margaret Peng; Delia Dempsey; Neal L Benowitz
Journal:  Br J Clin Pharmacol       Date:  2011-11       Impact factor: 4.335

3.  Subacute nicotine co-exposure has no effect on 2,2',3,5',6- pentachlorobiphenyl disposition but alters hepatic cytochrome P450 expression in the male rat.

Authors:  Marianna Stamou; Eric Uwimana; Brenna M Flannery; Izabela Kania-Korwel; Hans-Joachim Lehmler; Pamela J Lein
Journal:  Toxicology       Date:  2015-10-14       Impact factor: 4.221

Review 4.  Drug interactions with tobacco smoking. An update.

Authors:  S Zevin; N L Benowitz
Journal:  Clin Pharmacokinet       Date:  1999-06       Impact factor: 6.447

5.  Effects of nicotine on cytochrome P450 2A6 and 2E1 activities.

Authors:  Janne Hukkanen; Peyton Jacob Iii; Margaret Peng; Delia Dempsey; Neal L Benowitz
Journal:  Br J Clin Pharmacol       Date:  2010-02       Impact factor: 4.335

6.  Accumulation of mitochondrial P450MT2, NH(2)-terminal truncated cytochrome P4501A1 in rat brain during chronic treatment with beta-naphthoflavone. A role in the metabolism of neuroactive drugs.

Authors:  E Boopathi; H K Anandatheerthavarada; S V Bhagwat; G Biswas; J K Fang; N G Avadhani
Journal:  J Biol Chem       Date:  2000-11-03       Impact factor: 5.157

7.  Brain CYP2E1 is induced by nicotine and ethanol in rat and is higher in smokers and alcoholics.

Authors:  Lisa A Howard; Sharon Miksys; Ewa Hoffmann; Deborah Mash; Rachel F Tyndale
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

8.  Chronic nicotine treatment induces rat CYP2D in the brain but not in the liver: an investigation of induction and time course.

Authors:  Jiang Yue; Sharon Miksys; Ewa Hoffmann; Rachel F Tyndale
Journal:  J Psychiatry Neurosci       Date:  2008-01       Impact factor: 6.186

9.  Acetaldehyde and parkinsonism: role of CYP450 2E1.

Authors:  Francesca Vaglini; Cristina Viaggi; Valentina Piro; Carla Pardini; Claudio Gerace; Marco Scarselli; Giovanni Umberto Corsini
Journal:  Front Behav Neurosci       Date:  2013-06-21       Impact factor: 3.558

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.